FDA
approval
· 2024-10-31
FDA Approved: DILAUDID — Supplemental Application (Rhodes Pharmaceuticals L.P.)
Summary
FDA approved a supplemental application for DILAUDID (hydromorphone hydrochloride) filed by Rhodes Pharmaceuticals L.P.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DILAUDID (HYDROMORPHONE HYDROCHLORIDE)